ginkgolide b has been researched along with Angiogenesis, Pathologic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Han, Y; Hu, J; Jin, Z; Kong, L; Luo, J; Yang, L; Yu, P; Zhang, C; Zhao, C; Zhu, J | 1 |
He, X; He, Z; Hu, J; Ke, J; Lan, P; Li, S; Lian, L; Sun, L; Wu, X; Zou, Y | 1 |
Chen, XH; Liao, WH; Ou-Yang, XY; Wang, WJ | 1 |
3 other study(ies) available for ginkgolide b and Angiogenesis, Pathologic
Article | Year |
---|---|
Ginkgolide B targets and inhibits creatine kinase B to regulate the CCT/TRiC-SK1 axis and exerts pro-angiogenic activity in middle cerebral artery occlusion mice.
Topics: Animals; Brain Ischemia; Creatine Kinase; Endothelial Cells; Ginkgolides; Infarction, Middle Cerebral Artery; Ischemic Stroke; Lactones; Mice; Neovascularization, Pathologic; Neovascularization, Physiologic; Stroke | 2022 |
PAF receptor antagonist Ginkgolide B inhibits tumourigenesis and angiogenesis in colitis-associated cancer.
Topics: Animals; Azoxymethane; Carcinogenesis; Colitis; Dextran Sulfate; Female; Ginkgolides; Lactones; Mice; Neovascularization, Pathologic; Plant Extracts; Platelet Activating Factor | 2015 |
[Inhibitory effect of ginkgolide B on angiogenesis in chronic inflammation].
Topics: Animals; Cell Line; Diterpenes; Female; Fibrinolytic Agents; Fibroblasts; Ginkgolides; Granuloma; Humans; Inflammation; Interleukin-1; Lactones; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Platelet Activating Factor; RNA, Messenger; Tumor Necrosis Factor-alpha; U937 Cells | 2005 |